Serial Number 79172616
Registration 4934691
739

Registration Progress

Application Filed
Jul 27, 2015
Under Examination
Approved for Publication
Jan 26, 2016
Published for Opposition
Jan 26, 2016
Registered
Apr 12, 2016

Attorney Assistance

Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2016-04-12)
Due: Apr 12, 2026 274 days

Trademark Image

Basic Information

Serial Number
79172616
Registration Number
4934691
Filing Date
July 27, 2015
Registration Date
April 12, 2016
Published for Opposition
January 26, 2016
Drawing Code
2

Status Summary

Current Status
Active
Status Code
739
Status Date
Oct 6, 2022
Registration
Registered
Classes
005

Rights Holder

UCB BIOPHARMA SRL

99
Address
Allée de la Recherche 60
B-1070 Bruxelles
BE

Ownership History

UCB BIOPHARMA SRL

Original Applicant
99
BE

UCB BIOPHARMA SRL

Owner at Publication
99
BE

UCB BIOPHARMA SRL

Original Registrant
99
BE

Legal Representation

Attorney
Kumiko Ide

USPTO Deadlines

Next Deadline
274 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2016-04-12)
Due Date
April 12, 2026
Grace Period Ends
October 12, 2026

Application History

32 events
Date Code Type Description
Apr 12, 2025 REM4 E COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Oct 6, 2022 NA75 E NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Oct 6, 2022 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 6, 2022 C75A O REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Apr 12, 2022 ES75 I TEAS SECTION 71 & 15 RECEIVED
Apr 12, 2021 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 17, 2020 CORR I CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Aug 14, 2020 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB
Apr 23, 2020 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB
Aug 5, 2016 FINV P FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 14, 2016 FIMP P FINAL DISPOSITION PROCESSED
Jul 14, 2016 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Jul 12, 2016 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 12, 2016 R.PR A REGISTERED-PRINCIPAL REGISTER
Jan 26, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 26, 2016 PUBO A PUBLISHED FOR OPPOSITION
Jan 6, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 18, 2015 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 11, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 9, 2015 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 9, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 9, 2015 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 8, 2015 RFNT P REFUSAL PROCESSED BY IB
Oct 22, 2015 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 22, 2015 RFRR P REFUSAL PROCESSED BY MPU
Oct 21, 2015 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 20, 2015 CNRT R NON-FINAL ACTION WRITTEN
Oct 18, 2015 DOCK D ASSIGNED TO EXAMINER
Sep 23, 2015 MAFR O APPLICATION FILING RECEIPT MAILED
Sep 19, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 18, 2015 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 17, 2015 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 005
Pharmaceutical products and substances for the treatment of central nervous system diseases [ and for the treatment of immune system diseases ]

Additional Information

Design Mark
The mark consists of concentric circles representing the fanciful design of an eye inside a shaded quadrilateral with rounded corners.
Color Claim
The color(s) black and white is/are claimed as a feature of the cfstatements.

Classification

International Classes
005